Menu Search
Equities

Healthequity Inc

HQY:NSQ

Healthequity Inc

Actions
Health CareHealth Care Providers
  • Price (USD)78.59
  • Today's Change1.05 / 1.35%
  • Shares traded597.15k
  • 1 Year change+10.77%
  • Beta0.5244
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Healthequity Inc grew revenues 16.00% from 861.75m to 999.59m while net income improved from a loss of 26.14m to a gain of 55.71m.
Gross margin65.06%
Net profit margin9.61%
Operating margin15.50%
Return on assets3.21%
Return on equity5.15%
Return on investment3.32%
More ▼

Cash flow in USDView more

In 2024, Healthequity Inc increased its cash reserves by 58.88%, or 149.71m. The company earned 242.83m from its operations for a Cash Flow Margin of 24.29%. In addition the company used 46.07m on investing activities and also paid 47.04m in financing cash flows.
Cash flow per share3.00
Price/Cash flow per share25.65
Book value per share24.70
Tangible book value per share-8.54
More ▼

Balance sheet in USDView more

Healthequity Inc has a Debt to Total Capital ratio of 33.80%, a lower figure than the previous year's 44.81%.
Current ratio4.10
Quick ratio--
Total debt/total equity0.5106
Total debt/total capital0.338
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items increased 306.94%. Additionally, five year annualized earnings per share growth ranks below the industry average relative to its peers.
EPS growth(5 years)-11.29
EPS (TTM) vs
TTM 1 year ago		709.10
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.